13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03135327 (ClinicalTrials.gov) | January 1, 2007 | 24/4/2017 | Clinical Applications of Advanced Ophthalmic Imaging | Clinical Applications of Advanced Ophthalmic Imaging | Multiple Sclerosis;Dry Eye Syndromes;Diabetic Retinopathy;Presbyopia;Myopia;Dementia | Dietary Supplement: Ocufolin | University of Miami | NULL | Recruiting | 18 Years | 99 Years | All | 5000 | N/A | United States |